Timedora
Free Practice Quiz Question List

7 Antithrombotic Therapy and Bleeding Risk Online Quiz Questions

Use this free practice quiz with 20 questions to review 7 Antithrombotic Therapy and Bleeding Risk, test your knowledge, and prepare for your next test or exam.

20 questions
01
Choose one
1 point

A patient taking warfarin has a dose change and a new interacting medicine. Which monitoring approach is most appropriate?

  1. A

    Routine INR only, because it reliably measures every anticoagulant

  2. B

    PT/INR, with monitoring frequency adjusted to clinical circumstances

  3. C

    aPTT only, regardless of indication or dose

  4. D

    Platelet function testing at every dose

02
True or false
1 point

A normal PT/INR or aPTT excludes clinically important direct oral anticoagulant activity.

  1. A

    True

  2. B

    False

03
Written response
1 point

What medicine class does clopidogrel belong to?

04
Fill in the blank
1 point

For severe warfarin-related bleeding, a common reversal approach is plus , following local protocol.

05
Choose one
1 point

A patient taking dabigatran has life-threatening uncontrolled bleeding. Which specific reversal agent may be used?

  1. A

    Protamine

  2. B

    Andexanet alfa

  3. C

    Idarucizumab

  4. D

    IV vitamin K

06
Choose all
1 point

Which new findings in a patient receiving antithrombotic therapy warrant urgent assessment for possible thrombosis? Select all that apply.

  1. A

    New unilateral leg pain or swelling

  2. B

    A small bruise at an old injection site with no other symptoms

  3. C

    Sudden shortness of breath or chest pain

  4. D

    Acute facial droop, weakness, speech difficulty, or vision change

07
Written response
1 point

For therapeutic IV unfractionated heparin, name one test that may be used per protocol to monitor its effect.

08
True or false
1 point

There is no routine specific antidote for antiplatelet medicines.

  1. A

    True

  2. B

    False

09
Fill in the blank
1 point

For accessible external bleeding, apply firm when appropriate. Do not delay emergency to obtain routine tests.

10
Choose all
1 point

Which statements about antithrombotic reversal are consistent with safe clinical practice? Select all that apply.

  1. A

    Reversal is generally reserved for life-threatening, critical-site, or otherwise uncontrolled major bleeding.

  2. B

    A reversal agent should be used for routine minor bruising to prevent progression.

  3. C

    Reversal itself can increase clotting risk.

  4. D

    The decision should account for bleeding severity, drug exposure, renal function, laboratory findings, and thrombosis risk.

11
Choose one
1 point

A patient on long-term antithrombotic therapy reports minor bleeding but is otherwise stable. What is the most appropriate response?

  1. A

    Stop all antithrombotic therapy permanently without consulting anyone.

  2. B

    Notify the prescriber according to severity and local policy; do not independently stop long-term therapy unless an emergency protocol applies.

  3. C

    Ignore the bleeding unless the patient becomes hypotensive.

  4. D

    Give a reversal agent immediately for any minor bleeding.

12
Choose one
1 point

A patient realizes they missed an antithrombotic dose. Which general teaching is appropriate?

  1. A

    Do not double a missed dose; consult the clinician or follow the medicine-specific instructions.

  2. B

    Take two doses together to make up for the missed dose.

  3. C

    Stop the medicine until the next scheduled appointment.

  4. D

    Take an additional dose whenever a dose time is uncertain.

13
Choose one
1 point

A patient taking low-molecular-weight heparin develops severe bleeding. Which statement about reversal is accurate?

  1. A

    Idarucizumab completely reverses LMWH.

  2. B

    Protamine can partially reverse its effect.

  3. C

    IV vitamin K is its specific reversal agent.

  4. D

    No clinical assessment or bleeding-source management is needed.

14
Open ended
1 point

A patient taking apixaban develops suspected critical-site bleeding and becomes hemodynamically unstable. Describe the immediate nursing priorities, including escalation, assessment, medication information to obtain, and how to approach tests and treatment.

15
Choose one
1 point

A patient is prescribed a medicine to reduce platelet activation or aggregation to help prevent an arterial event. Which medicine class matches this purpose?

  1. A

    An anticoagulant, which acts on clotting factors

  2. B

    An antiplatelet medicine, which reduces platelet activation or aggregation

  3. C

    A reversal agent, which prevents all clot formation

  4. D

    A thrombolytic, which is used for routine prevention of arterial events

16
Written response
1 point

A patient takes warfarin. Which laboratory test is used to monitor its anticoagulant effect?

17
Written response
1 point

For therapeutic intravenous unfractionated heparin, name one test that may be used for monitoring according to protocol.

18
Choose one
1 point

A patient receiving enoxaparin is being reviewed for routine monitoring. Which plan best matches the usual approach?

  1. A

    Routine INR testing alone

  2. B

    Daily anti-Xa testing for every patient

  3. C

    CBC, renal function, and clinical bleeding assessment

  4. D

    Routine aPTT testing to measure platelet inhibition

19
True or false
1 point

True or false: A normal PT/INR or aPTT rules out clinically important anticoagulant activity from a direct oral anticoagulant.

  1. A

    True

  2. B

    False

20
Choose one
1 point

During medication reconciliation, a patient taking an antithrombotic reports using an over-the-counter NSAID. What is the best response?

  1. A

    Assume an over-the-counter medicine cannot affect bleeding risk

  2. B

    Review the NSAID with the care team because it may increase bleeding risk

  3. C

    Replace the prescribed antithrombotic with the NSAID

  4. D

    Stop all antithrombotic medicines without consulting the prescriber